ArticlePCN reports : psychiatry and clinical neurosciences2026
Catatonia with prominent psychosocial factors: A case report.
Article in PCN reports : psychiatry and clinical neurosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Catatonia with prominent psychosocial factors: A case report.PCN reports : psychiatry and clinical neurosciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Catatonia is a psychomotor syndrome historically linked to schizophrenia but now recognized across diverse psychiatric, medical, and psychosocial contexts. Detailed reports of catatonia arising amid pronounced psychosocial vulnerability remain scarce. We describe catatonia in a patient with co-occurring somatic symptom disorder, functional neurological symptom disorder (FNSD), and dissociative disorder that remitted with pharmacotherapy. Case Presentation: A man in his 40's with chronic physical illness and recurrent fears of abandonment by his partner developed functional and dissociative symptoms after his partner's surgery was scheduled and was admitted following the sudden onset of fragmented, childlike speech. No specific neurological or medical cause was identified, and no schizophrenia or mood disorder was present. He developed stupor, mutism, posturing, negativism, mannerisms, and stereotypy, meeting DSM-5-TR criteria for catatonia; the Bush-Francis Catatonia Rating Scale (BFCRS) score was 22. Under lorazepam 3 mg/day and quetiapine 600 mg/day, the BFCRS improved to 3 by hospital Day 34, but worsened during dose reduction of either drug and improved on re-escalation. He was discharged on hospital Day 98 with a BFCRS of 0, with no recurrence at 10 months. Conclusion: Catatonia can arise in patients with co-occurring somatic symptom disorder, FNSD, and dissociative disorder. In this patient, catatonia showed dose-dependent re-emergence during tapering of both lorazepam and quetiapine, with remission on re-escalation. Even when psychosocial factors appear prominent, careful monitoring and gradual dose adjustment may be important for maintaining remission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.